fingolimod "lupin" 0,5 mg kapsler, hårde
lupin europe gmbh - fingolimodhydrochlorid - kapsler, hårde - 0,5 mg
lutinus 100 mg vaginaltabletter
ferring lægemidler a/s - progesteron - vaginaltabletter - 100 mg
lutinus 100 mg vaginaltabletter
paranova danmark a/s - progesteron - vaginaltabletter - 100 mg
lutinus 100 mg vaginaltabletter
2care4 aps - progesteron - vaginaltabletter - 100 mg
lutinus 100 mg vaginaltabletter
orifarm a/s - progesteron - vaginaltabletter - 100 mg
lutinus 100 mg vaginaltabletter
abacus medicine a/s - progesteron - vaginaltabletter - 100 mg
saphnelo
astrazeneca ab - anifrolumab - lupus erythematosus, systemisk - immunosuppressiva - saphnelo is indicated as an add-on therapy for the treatment of adult patients with moderate to severe, active autoantibody-positive systemic lupus erythematosus (sle), despite standard therapy.
benlysta
glaxosmithkline (ireland) limited - belimumab - lupus erythematosus, systemisk - immunosuppressiva - benlysta er angivet som add-on terapi til patienter i alderen 5 år og ældre med en aktiv, autoantibody positive systemisk lupus erythematosus (sle) med en høj grad af sygdommens aktivitet (e. positive anti-dsdna og lave supplement), på trods af standard-terapi. benlysta is indicated in combination with background immunosuppressive therapies for the treatment of adult patients with active lupus nephritis.
lupkynis
otsuka pharmaceutical netherlands b.v. - voclosporin - lupus nephritis - immunosuppressiva - lupkynis is indicated in combination with mycophenolate mofetil for the treatment of adult patients with active class iii, iv or v (including mixed class iii/v and iv/v) lupus nephritis (ln).
namuscla
lupin europe gmbh - mexiletine hydrochloride - myotonic lidelser - hjertetapi - namuscla er indiceret til symptomatisk behandling af myotonia i voksne patienter med ikke-dystrofiske myotonic lidelser.